Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Portfolio consolidation.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Evaluation of CD4 in combination with CHO chemotherapy in subjects with nodal involvement of non cutaneous Tcell lymphoma.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1 | Experimental | CHOP chemo therapy + CD4 therapy |
|
| 2 | Active Comparator | CHOP chemotherapy |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| CHOP + CD4 | Biological |
| ||
| CHOP |
| Measure | Description | Time Frame |
|---|---|---|
| Primary Outcome Unavailable | All efforts to obtain data have been exhausted, therefore we have no data available to report. |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
All efforts to obtain data have been exhausted, therefore we have no data available to report.
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | 1 CHOP Chemo Therapy + CD4 Therapy CHOP + CD4 | CHOP chemo therapy + CD4 therapy CHOP + CD4 |
| FG001 | 2 CHOP Chemotherapy CHOP | CHOP chemotherapy CHOP |
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
All efforts to obtain data have been exhausted, therefore we have no data available to report.
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | 1 CHOP Chemo Therapy + CD4 Therapy CHOP + CD4 | CHOP chemo therapy + CD4 therapy CHOP + CD4 |
| BG001 | 2 CHOP Chemotherapy CHOP | CHOP chemotherapy CHOP |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Categorical |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Primary Outcome Unavailable | All efforts to obtain data have been exhausted, therefore we have no data available to report. | All efforts to obtain data have been exhausted, therefore we have no data available to report. | Posted |
|
|
Not provided
All efforts to obtain data have been exhausted, therefore we have no data available to report.
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | 1 CHOP Chemo Therapy + CD4 Therapy CHOP + CD4 | CHOP chemo therapy + CD4 therapy CHOP + CD4 |
Not provided
Not provided
All efforts to obtain data have been exhausted, therefore we have no data available to report.
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Clinical Development Representative | Emergent Biosolutions | ctgov@ebsi.com |
Not provided
| ID | Term |
|---|---|
| D016399 | Lymphoma, T-Cell |
| ID | Term |
|---|---|
| D008228 | Lymphoma, Non-Hodgkin |
| D008223 | Lymphoma |
| D009370 | Neoplasms by Histologic Type |
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| BG002 | Total | Total of all reporting groups |
|
| Age, Continuous |
| Sex: Female, Male |
|
| Counts |
|---|
| Participants |
|
| 0 |
| 0 |
| 0 |
| 0 |
| EG001 | 2 CHOP Chemotherapy CHOP | CHOP chemotherapy CHOP | 0 | 0 | 0 | 0 |
Not provided
Not provided
| D008232 |
| Lymphoproliferative Disorders |
| D008206 | Lymphatic Diseases |
| D006425 | Hemic and Lymphatic Diseases |
| D007160 | Immunoproliferative Disorders |
| D007154 | Immune System Diseases |